Cell-mediated immunity (CMI) to Bordetella pertussis and acellular pertussis vaccine constituents (pertussis toxin, pertactin, and filamentous hemagglutinin) were studied in peripheral blood mononuclear cells (PBMC) and T cell cultures from healthy adults with no record of vaccination against, or history of, pertussis. Similarly to stimulation with common recall antigens, PBMC proliferation was induced in 80% -100% of the cultures, depending on the specific B. pertussis stimulant. Proliferation did not occur when antigen-presenting cells were ablated by chemical or physical methods or with naive cord blood lymphocytes. B. pertussis antigen stimulation resulted in a preferential induction of type 1 cytokine profile, as shown by interferon-g and interleukin-2 (but no interleukin-4 or interleukin-5) gene transcripts and actual cytokine production by T cells. The data suggest that most healthy adults are repeatedly exposed to B. pertussis, with natural acquisition of antigenspecific CMI and a putatively protective type 1 cytokine pattern.
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The mechanisms of protective immunity against Bordetella
Methods pertussis infection following natural exposure or vaccination are still unclear. Immunogenicity studies during efficacy trials [1 -3] ). Consequently, cell-mediated immunity (CMI) has been Italy) were used as antigens. All preparations were heat-inactivated addressed, both in murine models of B. pertussis respiratory at 86ЊC for 1 h. infection and in children recovering from, or vaccinated Subjects. Peripheral blood from 16 volunteers (mean age, 40 against, pertussis [4 -8] . These studies suggest that CMI is years; range, 24-57) with no record of pertussis vaccination or probably an important host determinant of anti-pertussis resispertussis was used.
tance.
PBMC isolation, T cell enrichment, proliferation, and cytokine

CMI responses against B. pertussis antigens in adults have
assay. PBMC were isolated by centrifugation on density gradibeen little explored. Recent reports demonstrate that when perents and suspended in complete RPMI medium (GIBCO, Grand tussis vaccination of infants is largely implemented, adolesIsland, NY) supplemented with 5% pooled AB serum and antibicents and adults remain susceptible to infection by B. pertussis otics. In other experiments, mononuclear cells from cord blood and actually constitute the reservoir for children's infection [9, (CBMC) were used [11] . T cell -enriched cultures (hereafter re-10]. This makes it plausible to offer a booster dose of vaccine ferred to as T cells or T cell cultures) were obtained by immunofor adolescents and adults, also with the goal of preventing B. magnetic negative selection with Dynabead particles (Dynol, Oslo), as previously described [12] . The enrichment was considpertussis transmission from adults to infants. Knowledge of ered to be effective when T cells were ú90% CD3 and õ1% the CMI response in adults may give some critical insights into In this pilot study, we have addressed peripheral blood monodefinition) on stimulation by anti-CD3 monoclonal antibody [12] . nuclear cell (PBMC) proliferation and cytokine production by vaccination.
Louis) [13] .
Cell proliferation was assayed by using 10 6 cells/mL in 0.2 mL of complete medium in the presence of a predetermined optimal dose of each stimulant. The plates were incubated at 37ЊC in 5% 467 JID 1998; 178 (August) Immunity to B. pertussis in Adults
Cytokines in culture supernatants were measured by ELISA (Quantikine; R&D Systems, Minneapolis).
Polymerase chain reaction (PCR)-assisted mRNA amplification. Total cellular RNA was extracted by the guanidinium isothiocyanate method, reverse-transcribed, and subjected to PCR reactions, as described elsewhere [11] . The reaction product was visualized by electrophoresis. The relative density of the ethidium bromide-stained PCR reaction products was determined by using a Scanning Densitometer CS-9301PC (Shimadzu, Columbia, MD). The actual densitometric values for each cytokine mRNA were normalized against b-actin band density taken as the 100% reference, and all other values were expressed as a percentage of this figure [12] .
Results
In preliminary experiments, the optimal concentration of each B. pertussis stimulant for both PBMC proliferation and cytokine production was established (10 6 cfu/mL for B. pertussis and 10, 20, and 20 mg/mL for PT, PRN, and FHA, respectively). These experiments also showed that kinetics of PBMC proliferative response to all preparations reached the maximum values after 7 days, as typical of memory recall antigen stimulation. Thus, all subsequent experiments were done under the above experimental conditions. PBMC proliferation. The PBMC of all 16 subjects proliferated in response to B. pertussis and PRN, while those of 12 and 14 of 15 subjects examined responded to PT and FHA, respectively. The degree of proliferation induced by PT or FHA (mean { SD, 9.5 { 1.5 and 18.5 { 3.5 1 10 3 cpm, respectively) was significantly lower than that induced by PRN (30.3 { 4.7) or B. pertussis (34.6 { 3.6). (All values are given after subtraction of the cpm of the unstimulated control).
To rule out a possible mitogenic or superantigenic activity of B. pertussis antigens (despite their use as heat-inactivated preparations), naive lymphocytes from cord blood (CBMC) were isolated and their proliferation tested in comparison with PBMC from a subject responsive to all B. pertussis antigens. Figure 1A shows that these antigens induced very low, if any, CBMC proliferation, compared with the high proliferative responses of PBMC. In contrast, CBMC were, as were PBMC, representative data obtained from PBMC of 5 donors (figure 3, upper left) and the corresponding T cell cultures (figure 3, Figure 2 shows the cytokine mRNA signals in PBMC and in T cell cultures from a representative donor. It shows that lower left).
To confirm that gene expression was actually translated into most cytokines tested were expressed in B. pertussis antigenactivated PBMC, and the intensity of the signals depended on the cytokine products and reflected the differential cytokine gene expression patterns shown by proliferating PBMC and the single stimulating antigen. However, IL-4 and IL-5 signals had low or no intensity, whichever the B. pertussis antigen nonproliferating T cell cultures, we assayed the supernatants of both PBMC and T cell cultures of the same 5 subjects for used. Figure 2 also shows that granulocyte-macrophage colonyproduction of representative Th1 and Th2 cytokines. Despite large subject-to-subject variations, figure 3 (right) confirms that both IFN-g and IL-10 were produced by B. pertussis antigenstimulated PBMC, whereas only the former was present in the supernatant of T cell cultures. No or minimal IL-5 was produced by either PBMC or T cells. Together, these data confirm the cytokine gene expression patterns and demonstrate that IL-10, IL-6, and tumor necrosis factor-a are not produced by T cells under our stimulation conditions. Addition of irradiated APC to B. pertussis -stimulated T cells did not affect the amount of IFN-g production, nor did it stimulate appreciable IL-5 production (data not shown).
Discussion
Recent investigations in immunized children demonstrate that CMI responses to B. pertussis antigens constitute a relevant feature of pertussis vaccine immunogenicity and, as suggested by animal studies [14] , may contribute to the vaccine efficacy [5, 6, 8] . Similarly, determinations of B. pertussis -specific CMI responses in adults may provide valuable information for any potential adult immunization.
Very little is indeed known about CMI responses to B. pertussis antigens in adults. One study has been done with T cell lines and clones from a single adult who had pertussis in his childhood, and other data by the same group of investigators demonstrated the persistence of antibody and CMI levels to . After 48 h, cells were harvested and RNA was extracted and reverse-transcribed. cDNA obtained was assayed for presence of specific cytokine mRNA by polymerase chain reaction. Reaction products were run on 1% agarose gel. For each cytokine signal, data are % absorbance (mean { SE) of b-actin signal as control of in-house gene expression (left). Cytokines: IL, interleukin; TNF, tumor necrosis factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon. Cytokine production by B. pertussis antigen -stimulated PBMC and T cells was quantified as described for cytokine mRNA quantitation. Amount of IFN-g, IL-10, and IL-5 in culture supernatants was assayed by ELISA. Data are expressed as pg/mL (mean { SE) (right).
by the lack of lymphoproliferation of mitogen-responsive, nawell as the negative history of pertussis. Notably, in a previous study of humoral and cellular markers of prevalence of ive cord blood cells; resulted in a typical Th1 cytokine profile (abundant IFN-g and presence of IL-2 transcripts, with no or exposure to B. pertussis in 62 military recruits in Italy [16], we found that the PBMC of the large majority of them prolifvery low production of IL-4 or IL-5); and was reflected in the ability of T cells to produce type 1 cytokines on stimulation erated in response to the B. pertussis antigens, and the degree of proliferation was comparable in those with or without by B. pertussis antigens even without cell proliferation.
The extensive priming of Italian adults to B. pertussis history of pertussis. It is also unlikely that B. pertussisspecific CMI in adults depends exclusively or predominantly antigens is unlikely to depend on vaccination or pertussis in infancy, given the random selection of the blood donors in on exposure to cross-reacting antigens, as was also seen with PT and PRN, which are specific B. pertussis antigens. It more this study, the absence of a record of vaccination, and the low anti-pertussis vaccination coverage in our country, as likely reflects the acquisition of exposure-induced immunity,
